Relevant bibliographies by topics / Vulvar cancer in situ

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Vulvar cancer in situ'

Author: Grafiati
Published: 3 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Vulvar cancer in situ.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Vulvar cancer in situ"

1

SPIRYDA, L. B., A. F. FULLER, and A. GOODMAN. "Aggressive locally recurrent vulvar cancer: review of cases presented to Massachusetts General Hospital 1990 to present." International Journal of Gynecologic Cancer 15, no. 5 (2005): 884–89. http://dx.doi.org/10.1136/ijgc-00009577-200509000-00027.

Full text
Abstract:
Isolated recurrences of squamous cell vulvar carcinoma treated by surgical reexcision have excellent outcomes. There is a subset of these patients who develop multiple local recurrences that are difficult to manage and have a high risk of dying from their cancers. We reviewed women presenting with vulvar cancer (200 patients) to Massachusetts General Hospital from 1990 to present and identified 12 women with aggressive, locally recurrent squamous cell carcinomas of the vulva. The identified women all had successful primary radical vulvectomy and groin node dissections with negative surgical ma
APA, Harvard, Vancouver, ISO, and other styles
2

Dunaevskaya, V. "Characteristics of vaginal and vulvar microbiota in patients with vulvar precancerous lesions and vulvar squamous cell carcinoma." Journal of Education, Health and Sport 52 (January 31, 2024): 267–77. http://dx.doi.org/10.12775/jehs.2024.52.112.

Full text
Abstract:
The aim of the study was to analyze the composition of the microbiota of the vagina and vulva in patients with precancerous lesions of the vulva in comparison with healthy controls and in women with vulvar cancer. Materials and methods. 286 women with vulvar lesions aged from 25 to 70 years and 60 gynecologically healthy women (30 under 50 years and 30 after 50 years) were included in the study. Patients with vulvar lesions were divided into 5 groups: 87 women with high-grade intraepithelial neoplasia of the vulva (VHSIL) dependent on the human papilloma virus (HPV) (Group 1 - G1), 154 women w
APA, Harvard, Vancouver, ISO, and other styles
3

Laukaitytė, Odeta, Gustė Brazytė, Tadas Latkauskas, and Saulius Paškauskas. "Concurrent Occurrence of Rectal Adenocarcinoma and Vulvar Keratinizing Squamous Cell Carcinoma: Case Report and Literature Review." Lietuvos chirurgija 24, no. 3 (2025): 212–20. https://doi.org/10.15388/lietchirur.2025.24(3).5.

Full text
Abstract:
Introduction. Vulvar carcinoma is a rare malignancy, whereas rectal cancer is a more common oncological condition. However, the simultaneous occurrence of these two diseases is exceptionally rare. Case presentation. A 76-year-old woman presented with rectal bleeding and was previously diagnosed with keratinizing squamous cell carcinoma G1 of the vulva, unrelated to HPV. Imaging revealed tumor-like masses in the vulva and rectum, with pathological lymph nodes. Biopsy confirmed rectal adenocarcinoma in situ. She underwent obstructive rectal resection, colostomy formation, vulvar resection, and l
APA, Harvard, Vancouver, ISO, and other styles
4

Navarro Elias, Gallardo, Adriana Margarita Acosta Blanco, Mancera Steiner Carlos, and Francisco Garcia Rodriguez. "Squamous cell carcinoma in situ of the vulva." Hematology & Transfusion International Journal 11, no. 4 (2023): 119–21. http://dx.doi.org/10.15406/htij.2023.11.00318.

Full text
Abstract:
Currently, squamous vulvar cancer is rare, which is why there is limited experience among health personnel in recognizing and managing this type of tumor location. The purpose of this case is to present the case of an 87-year-old woman with an ulcerative lesion on the vulva who underwent left vulvectomy with a report of squamous cell carcinoma in situ pathology, with favorable post-surgical evolution and without the need for adjuvant treatment when the inguinal lymph node was negative for metastasis.
APA, Harvard, Vancouver, ISO, and other styles
5

Secară, Diana, Daniela Meca, Sorin Vasilescu, et al. "Muscle-skeletal metastatic pattern in vulvar cancer." Romanian Journal of Orthopaedic Surgery and Traumatology 4, no. 2 (2021): 78–82. http://dx.doi.org/10.2478/rojost-2021-0014.

Full text
Abstract:
Abstract Vulvar cancer is a rare malignancy of the genital tract, the fourth most common type in this category. The most common form of the clinical appearance is long-lasting pruritus, a lump or mass on the vulva. Despite its histological type, in most cases, invasive vulvar cancer metastasizes primarily through the lymphatic system. Bone metastases related to gynecological cancers are rare, often underdiagnosed, and have a very poor prognosis. The most common site of metastasis in vulvar cancer is the lung, which is affected in about 45%, followed closely by the liver and brain. Bone metasta
APA, Harvard, Vancouver, ISO, and other styles
6

Siegel, David A., Reda Wilson, Edward J. Wilkinson, et al. "Evaluation of the Vulvar Cancer Histology Code Reported by Central Cancer Registries: Importance in Epidemiology." Archives of Pathology & Laboratory Medicine 141, no. 1 (2016): 139–43. http://dx.doi.org/10.5858/arpa.2015-0422-oa.

Full text
Abstract:
Context.—Knowing the subtype of vulvar cancer histology is important for estimating human papillomavirus–related cancer etiology. Surveillance of human papillomavirus–related vulvar cancers informs public health decisions related to vaccination against human papillomavirus. Objective.—To assess the accuracy of registry classifications of vulvar cancer and determine the histologic classification of cases reported as not otherwise specified. Design.—Pathology specimens were collected from Florida, Iowa, and Hawaii cancer registries. Registry diagnosis was compared with the pathology report from
APA, Harvard, Vancouver, ISO, and other styles
7

Gebauer, G., J. Schleibaum, S. Aulmann, P. Schirmacher, C. Sohn, and P. Sinn. "Low-level amplifications of the human telomerase gene (TERC) regularly is associated with vulvar intraepithelial neoplasia." Journal of Clinical Oncology 24, no. 18_suppl (2006): 20060. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.20060.

Full text
Abstract:
20060 Background: Invasive squamous carcinomas of the vulva frequently harbor gains on the long arm of chromosome 3, including the human telomerase gene locus (TERC). Vulvar cancer develops from precursor lesions known as vulvar intraepithelial neoplasia (VIN) which frequently occur simultaneously in multiple locations and have a considerable risk or recurrence during follow-up. We investigated TERC gene copy number in a series of vulvar intraepithelial neoplasias to determine the risk of progression in these lesions. Methods: A total of 20 cases of high grade vulvar intraepithelial neoplasias
APA, Harvard, Vancouver, ISO, and other styles
8

Wu, Fiona, Uzma Andaleeb, and Ibrahim Ahmed. "Extramammary breast cancer of the vulva." BMJ Case Reports 17, no. 7 (2024): e259567. http://dx.doi.org/10.1136/bcr-2023-259567.

Full text
Abstract:
A woman in her 70s was seen in the gynaecology outpatient clinic with a swelling on the right side of the vulva. Surgical excision of the lesion revealed unexpectedly an extensive ductal carcinoma in situ with a focus of a grade 2 invasive ductal carcinoma arising in extramammary breast tissue of the vulva. Postoperative staging studies showed normal breasts, with no evidence of disease elsewhere. The patient underwent a wider excision of the right vulva and sentinel node biopsy of the right inguinal region, which revealed no further disease. The patient is currently taking adjuvant hormonal t
APA, Harvard, Vancouver, ISO, and other styles
9

Swierczek, Sabina, Deep Pandya, Jean-Noel Billaud, et al. "Abstract 70: Metastatic versus primary: Genomic analysis suggests a metastatic origin for breast cancer previously diagnosed as metachronous vulvar ectopic breast cancer." Cancer Research 82, no. 12_Supplement (2022): 70. http://dx.doi.org/10.1158/1538-7445.am2022-70.

Full text
Abstract:
Abstract Introduction: Accessory breast tissue is a rare finding in the general population with an incidence of 1-2%. Ectopic mammary tissue may occur anywhere along the milk line, from the axilla to the groin. Thus, breast cancer present in the vulva may arise as a primary breast adenocarcinoma or distant metastasis. Differentiating the two can be clinically challenging but is critically important as it impacts prognosis and treatment. Using genomic and bioinformatic approaches, we re-evaluated a previously histopathologically diagnosed rare case of metachronous vulvar ectopic breast cancer.
APA, Harvard, Vancouver, ISO, and other styles
10

Rosin, Jennifer, and Peter T. Silberstein. "Vulvar cancer: Presentation and treatment variation among races." Journal of Clinical Oncology 31, no. 15_suppl (2013): 5611. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.5611.

Full text
Abstract:
5611 Background: Vulvar cancer is the fourth most common gynecologic malignancy. We analyzed variation among races in treatment, histology and stage at presentation using the National Cancer Database (NCDB). Methods: Between 2000 and 2010, 51,157 women from 1338 hospitals across the US were reported to the NCDB with vulvar cancer. Differences were assessed using Chi square analysis. Results: Caucasian patients with vulvar carcinoma in situ received no first course treatment significantly less than African American or Hispanic patients (3% vs 6% and 7%, p<0.05). No treatment for stage I and
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Vulvar cancer in situ"

1

Madeleine, Margaret M. "Three case-control studies : vulvar cancer, invasive cervical cancer, and in situ adenocarcinoma of the cervix /." Thesis, Connect to this title online; UW restricted, 1996. http://hdl.handle.net/1773/10895.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

LEFEUVRE, BRIGITTE. "Le traitement par le laser co2 des lesions de la vulve : a propos de 79 observations." Nantes, 1988. http://www.theses.fr/1988NANT025M.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

黃鳳如 and Fung-yu Huang. "Molecular and cytogenetic analysis of cervical and vulvar cancer." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2002. http://hub.hku.hk/bib/B26662188.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

MALBERTI, SILVIA. "Carcinoma della vulva recidivo dopo chirurgia o localmente avanzato: ruolo e possibilità di chemioterapia neoadiuvante." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2011. http://hdl.handle.net/10281/28328.

Full text
Abstract:
Background: no standard treatment are avaliable for patients with locally advanced or recurrent vulvar cancer Patients and Methods:35 patients with recurrent and 26 patients with locally advanced vulvar cancer received paclitaxel/cisplatin and or without ifosfamide every 3 weeks for up to 6 cycles. Primary objective was response rate and operability rate. Secondary objective were response duration and toxicity. Response evaluation was assessed by WHO criteria; tossicity according to common toxicity criteria. Results: Sixty-one women were included with a median age of 75 (range 43-85). On st
APA, Harvard, Vancouver, ISO, and other styles
5

Murray, Abner A. "Plant Virus Nanoparticle In Situ Cancer Immunotherapies." Case Western Reserve University School of Graduate Studies / OhioLINK, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=case1532370850718292.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

UZAN, ERIC. "Les carcinomes mammaires in situ." Amiens, 1992. http://www.theses.fr/1992AMIEM089.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Makkouk, Amani Riad. "Biodegradable microparticles for in situ immunization against cancer." Diss., University of Iowa, 2014. https://ir.uiowa.edu/etd/1484.

Full text
Abstract:
Cancer immunotherapy has proven to be challenging as it depends on overcoming multiple mechanisms that mediate immune tolerance to self-antigens. In situ immunization is based on the concept that it is possible to break immune tolerance by inducing tumor cell death in situ in a manner that provides antigen presenting cells such as dendritic cells (DCs) with a wide selection of tumor antigens that can then be presented to the immune system and result in a therapeutic anticancer immune response. Based on recent advances in the understanding of antitumor immunity, we designed a three-step approac
APA, Harvard, Vancouver, ISO, and other styles
8

Hussain, Shehnaz Khursheed. "Genetic variation in immune regulatory cytokine genes, cigarette smoking, and human papillomavirus-associated cancer risk /." Thesis, Connect to this title online; UW restricted, 2006. http://hdl.handle.net/1773/10940.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Линдін, Микола Сергійович, Николай Сергеевич Лындин, Mykola Serhiiovych Lyndin, et al. "Prognostic value of CEACAM1 in breast cancer in situ." Thesis, Springer, 2019. http://essuir.sumdu.edu.ua/handle/123456789/75201.

Full text
Abstract:
Background & Objectives: Ductal breast cancer can be divided into invasive and non-invasive types (cancer in situ – DCIS). Although there is information about molecular features of these tumours, DCIS remains none fully described pathology. Thus we need to find novel reliable diagnostic markers. One could be the сarcinoembryonic antigen related cell adhesion molecules 1 (CEACAM1). This molecule was described in diverse invasive types of cancers. The aim our study presented here was to characterise the exact expression pattern of CEACAM1 in various types of DCIS.
APA, Harvard, Vancouver, ISO, and other styles
10

Guimaraes-Young, Amy. "Gynecological tissue homeostasis and tumorigenesis studies using mouse models." Diss., University of Iowa, 2017. https://ir.uiowa.edu/etd/5942.

Full text
Abstract:
Gynecological cancers present a tremendous disease burden worldwide. Endometrial cancer, the most common gynecological malignancy, is predominantly a disease of deranged glandular function. The mechanisms by which known environmental risk factors influence the mutational profile of endometrial cancer are poorly understood. Non-HPV vulvar cancer, on the other hand, is a very rare gynecological malignancy of vulvar squamous cells with little known about its pathogenesis. Surgical resection of vulvar cancer is associated with high post-surgical morbidity. Pivotal to improving treatment and outcom
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Vulvar cancer in situ"

1

Newman, Lisa A., and Jessica M. Bensenhaver, eds. Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer. Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-2035-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

J, Wilkinson Edward, ed. Pathology of the vulva and vagina. Churchill Livingstone, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

1940-, Hayat M. A., ed. Handbook of immunohistochemistry and in situ hybridization of human carcinomas. Elsevier Academic Press, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Burrows, Lara. 100 questions and answers about vulvar cancer and other diseases of the vulva and the vagina. Jones and Bartlett Publishers, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hayat, M. A. Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas: Molecular Pathology, Colorectal Carcinoma, and Prostate Carcinoma. Elsevier, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

J, Silverstein Melvin, ed. Ductal carcinoma in situ of the breast. Williams & Wilkins, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Virnig, Beth. Diagnosis and management of ductal carcinoma in situ (DCIS). Agency for Healthcare Research and Quality, Dept. of of Health and Human Services, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Alers, J. C. Interphase cytogenetic analysis of solid tumors by non-isotopic DNA in situ hybridization. Gustav Fischer, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gold, Heather Taffet. Do variations in treatment of ductal carcinoma in situ affect outcomes? Dept. of Community and Preventive Medicine, School of Medicine and Dentistry, University of Rochester, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Mikael, Rørth, ed. Carcinoma-in-situ and cancer of the testis: Biologyand treatment : proceedings of a workshop held in Copenhagen, Denmark, August 1986. Blackwell Scientific, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Vulvar cancer in situ"

1

Doner, Serife Irem, and Meltem Ugurlu. "Pregnancy and Birth in Cancer Patients." In Oncological Rehabilitation a Handbook for Healthcare Professionals. Nobel Tip Kitabevleri, 2024. http://dx.doi.org/10.69860/nobel.9786053358893.9.

Full text
Abstract:
Cancer is the second leading cause of death in women of reproductive age. Pregnancy and birth in women with cancer is a psychologically, physiologically and medically sensitive issue. This book chapter deals with the diagnostic and therapeutic approaches that should be followed in women diagnosed with cancer and experiencing pregnancy, birth and postpartum period. Diagnosis and treatment of cancers during pregnancy should be carefully planned according to trimesters in terms of both maternal and foetal health. Chemotherapy and radiotherapy in the first trimester are usually delayed because the
APA, Harvard, Vancouver, ISO, and other styles
2

Smith, Ashlee, and Kristin K. Zorn. "Vulvar Cancer." In Sexually Transmitted Diseases. Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781118314937.ch14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Choi, Serah, and Tracy Sherertz. "Vulvar Cancer." In Handbook of Evidence-Based Radiation Oncology. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-62642-0_33.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Shiao, Stephen, Brian Missett, and Joycelyn L. Speight. "Vulvar Cancer." In Handbook of Evidence-Based Radiation Oncology. Springer New York, 2010. http://dx.doi.org/10.1007/978-0-387-92988-0_33.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Runowicz, Carolyn D. "Vulvar Cancer." In The American Cancer Society's Oncology in Practice. John Wiley & Sons, Inc., 2018. http://dx.doi.org/10.1002/9781118592168.ch23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ma, Weining. "Vulvar Cancer." In Atlas of Gynecologic Oncology Imaging. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-7212-4_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Renz, Malte, Elisabeth J. Diver, Whitfield B. Growdon, and Oliver Dorigo. "Vulvar Cancer." In Synopsis of Key Gynecologic Oncology Trials, 2nd ed. CRC Press, 2022. http://dx.doi.org/10.1201/9781003229711-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Garda, Allison E., Loren K. Mell, and Ivy A. Petersen. "Vulvar Cancer." In Practical Guides in Radiation Oncology. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-99590-4_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mundt, Arno J., Catheryn Yashar, and Loren K. Mell. "Vulvar Cancer." In Target Volume Delineation and Field Setup. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-28860-9_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Vargo, John A., and Sushil Beriwal. "Vulvar Cancer." In Target Volume Delineation for Conformal and Intensity-Modulated Radiation Therapy. Springer International Publishing, 2014. http://dx.doi.org/10.1007/174_2014_981.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Vulvar cancer in situ"

1

Jain, Vandana, Rupinder Sekhon, Shveta Giri, and Sudhir Rawal. "R-veil in carcinoma vulva." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685390.

Full text
Abstract:
Background: Vulvar cancer accounts for about 3-5% of gynaecologic malignancies. Prognosis is strongly dependent on presence of inguinofemoral lymph node metastases. Effective management of regional lymph nodes is the most important factor in the curative management of early vulvar cancer. Despite careful dissection and maintaining vascularity of skin, surgical morbidity is seen in 50% cases. Video – endoscopic inguinofemoral lymphadenectomy was developed by Bishoff in 2003 by dissecting two cadaveric models and in one patient with stage T3N1M0 penile carcinoma. VEIL is an alternative to reduce
APA, Harvard, Vancouver, ISO, and other styles
2

Jain, Vandana, Rupinder Sekhon, Shveta Giri, and Sudhir Rawal. "R-VEIL in carcinoma vulva." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685393.

Full text
Abstract:
Background: Vulvar cancer accounts for about 3-5% of gynaecologic malignancies. Prognosis is strongly dependent on presence of inguinofemoral lymph node metastases. Effective management of regional lymph nodes is the most important factor in the curative management of early vulvar cancer. Despite careful dissection and maintaining vascularity of skin, surgical morbidity is seen in 50% cases. Video – endoscopic inguinofemoral lymphadenectomy was developed by Bishoff in 2003 by dissecting two cadaveric models and in one patient with stage T3N1M0 penile carcinoma. VEIL is an alternative to reduce
APA, Harvard, Vancouver, ISO, and other styles
3

Liu, Penglin, and Jinwei Miao. "157 The prognostic significance of primary tumor site in vulvar cancer: a population-based cohort study." In ESGO 2024 Congress Abstracts. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/ijgc-2024-esgo.68.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Szubert, M., M. Lec, K. Molisak, A. Rycerz, A. Nowak, and JR Wilczynski. "551 Vulvar cancer – still silent killer?" In ESGO 2021 Congress. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/ijgc-2021-esgo.624.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Atfi, Fadwa, Soukaina Sabir, Hajar Elomri, and Bensouda Mohamed El Mehdi. "661 Vulvar cancer: about 58 cases." In ESGO 2024 Congress Abstracts. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/ijgc-2024-esgo.1053.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mikami, Mikio. "Inguinofemoral lymph node dissection for vulvar cancer." In The 7th Biennial Meeting of Asian Society of Gynecologic Oncology. Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology, 2021. http://dx.doi.org/10.3802/jgo.2021.32.s1.m24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zahra, Mark A. "445 Outcomes after radiotherapy for vulvar cancer." In ESGO 2024 Congress Abstracts. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/ijgc-2024-esgo.1046.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Telisnor, Guettchina, Rishabh Garg, Yingwei Yao, Judith Schlaeger, and Diana J. Wilkie. "Abstract PO-269: Documentation methods for vulvar pain: Implications for detection of vulvar cancer, a cancer with known disparities." In Abstracts: AACR Virtual Conference: Thirteenth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; October 2-4, 2020. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7755.disp20-po-269.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Aur, Cristina, Diana Mocuta, and Monica Boros. "2022-RA-1396-ESGO Pregnancy- related vulvar cancer." In ESGO 2022 Congress. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/ijgc-2022-esgo.383.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jellouli, Asma, Sirine Bayar, Haithem Aloui, et al. "#1101 Diagnostic and therapeutic approach to vulvar cancer." In ESGO 2023 Congress. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/ijgc-2023-esgo.843.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Vulvar cancer in situ"

1

Claus, Elizabeth. Genetic Epidemiology of In Situ Breast Cancer. Defense Technical Information Center, 1999. http://dx.doi.org/10.21236/ada394225.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Claus, Elizabeth B. Genetic Epidemiology of in situ Breast Cancer. Defense Technical Information Center, 1998. http://dx.doi.org/10.21236/ada370308.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dash, Alekha K. Novel in Situ Gel Drug Delivery System for Breast Cancer Treatment. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada474685.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Li, Christopher I., Kathleen Malone, Janet Daling, and Peggy Porter. Use of Exogenous Progestins and Risk of in Situ and Invasive Breast Cancer. Defense Technical Information Center, 2010. http://dx.doi.org/10.21236/ada536888.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Li, Christopher I. Use of Exogenous Progestins and Risk of In Situ and Invasive Breast Cancer. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada541858.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Thompson, Timothy C. In Situ Gene Therapy for Prostate Cancer: Development of Systemic Anti-Tumor Immunity. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada415519.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Li, Christopher, Kathleen Malone, Janet Daling, and Peggy Porter. Use of Exogenous Progestins and Risk or In Situ and Invasive Breast Cancer. Defense Technical Information Center, 2009. http://dx.doi.org/10.21236/ada516616.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Li, Christopher I. Use of Exogenous Progestins and Risk of In Situ and Invasive Breast Cancer. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada460813.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Dharmawardhane, Suranganie F. In Situ Evaluation of the Role of the Small GTPase Rac3 in Breast Cancer. Defense Technical Information Center, 2005. http://dx.doi.org/10.21236/ada443694.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dharmawardhane, Suranganie F. In Situ Evaluation of the Role of the Small GTPase Rac3 in Breast Cancer Metastasis. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada426223.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Vulvar cancer in situ' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography